BIO-key International
BKYI
2 hedge funds and large institutions have $240K invested in BIO-key International in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
26% more capital invested
Capital invested by funds: $190K → $240K (+$50K)
0% less ownership
Funds ownership: 0% → 0% (-0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.3K |
Top Sellers
BKYI Hedge Fund Activity: Q2 2018 in Review
2 of the 4,384 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q2 2018, worth a combined $240K — up 26% from $190K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BKYI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $3.3K.
- 2 institutional investors held BIO-key International (BKYI) as of Q2 2018, up from 1 in Q1 2018.
- Funds reported $240K of BIO-key International stock for Q2 2018, up 26% quarter-over-quarter.
- 1 fund opened new BIO-key International positions in Q2 2018 and 0 closed out, a net change of +1 holder.
- The largest BIO-key International buyer in Q2 2018 was UBS Group, an estimated $3.3K added.
Based on aggregated 13F filings for Q2 2018.